Vranovska nemocnica a.s.

At Vranovska nemocnica a.s., clinical research in cardiovascular diseases focuses on major conditions such as atherosclerotic cardiovascular disease, elevated Lp(a), and the prevention of ischemic stroke after recent non-cardioembolic stroke or high-risk transient ischemic attack. The trials are designed to assess whether new treatments can better reduce future cardiovascular events and improve protection against serious clot-related complications.

• Testing new approaches to lower the risk of stroke after a recent ischemic event
• Evaluating treatments aimed at reducing major cardiovascular events in adults with elevated lipoprotein(a)
• Studying the effectiveness and safety of therapies added to standard antiplatelet treatment

This work reflects a strong interest in improving both prevention and long-term outcomes for patients at risk of serious cardiovascular complications.

The Neurologicke oddelenie is also involved in research on congenital and hereditary diseases, especially haemophilia A with or without factor VIII inhibitors. These studies aim to better understand long-term treatment performance and support safer, more effective care for people living with this inherited bleeding disorder.

• Investigating the long-term safety of a new preventive treatment for haemophilia A
• Assessing treatment options for patients with and without FVIII inhibitors
• Expanding evidence for care in both older patients and infants with inherited bleeding risk

This area of research is particularly important for improving everyday disease control and reducing bleeding-related complications across different patient groups.